Stock Futures Up, Early Risers Edwards (EW), Tesla (TSLA)

Stock futures stitched tight gains Monday morning as commodities markets lulled and stocks in Europe pushed marginally higher. Early risers included Edwards Lifesciences (EW) and Tesla Motors (TSLA), Investor’s Business Daily reported.

The only economic release expected today is February factory orders from the Commerce Department. Services sector data for March are expected on Tuesday. The high point in a quiet week of economic news is likely to be minutes from the Federal Open Market Committee’s March 16 meeting, which are due out Wednesday and will be closely watched. Boston Federal Reserve Bank President Eric Rosengren speaks this morning.

Medical devices leader Edwards Lifesciences bolted 13% higher after announcing positive results on a clinical trial for its SAPIEN 3 aortic valve replacement.

Tesla Motors rose 4% after a tweet from Chief Executive Elon Musk announced orders for the new Tesla Model 3 rose to 276,000 by the end of the day Saturday.

EW is a Cabot Top Ten Trader stock and TSLA is a Cabot Stock of the Month.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >